# Evaluation of Efficacy of Platelet Rich Plasma as Anew Modality for Treatment of Atrophic Rhinitis

> **NCT04717960** · NA · UNKNOWN · sponsor: **Sohag University** · enrollment: 40 (estimated)

## Conditions studied

- Atrophic Rhinitis

## Interventions

- **PROCEDURE:** nasal submucosal injection of platelet rich plasma

## Key facts

- **NCT ID:** NCT04717960
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2022-10
- **Final completion:** 2023-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04717960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04717960, "Evaluation of Efficacy of Platelet Rich Plasma as Anew Modality for Treatment of Atrophic Rhinitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04717960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*